Published in
Elsevier, The Lancet Oncology, 7(19), p. 916-929, 2018
DOI: 10.1016/s1470-2045(18)30254-7
Links
Tools
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial
Journal article published in 2018 by
Brigitte Dreno,
John F. Thompson,
Bernard Mark Smithers 
,
Mario Santinami,
Thomas Jouary,
Ralf Gutzmer,
Evgeny Levchenko,
Piotr Rutkowski,
Jean-Jacques Grob,
Sergii Korovin,
Kamil Drucis,
Florent Grange,
Laurent Machet,
Peter Hersey,
Ivana Krajsova
and other authors.
,
Mario Santinami,
Thomas Jouary,
Ralf Gutzmer,
Evgeny Levchenko,
Piotr Rutkowski,
Jean-Jacques Grob,
Sergii Korovin,
Kamil Drucis,
Florent Grange,
Laurent Machet,
Peter Hersey,
Ivana Krajsova
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 